Clinical trial
Lanadelumab for Treatment of COVID-19 Disease
NCT04422509 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lanadelumab for Treatment of COVID-19 Disease
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 30, 2020
- Completion date
- April 30, 2021
- Enrollment
- 43 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.